Your browser doesn't support javascript.
loading
Roles of exosomal circRNAs in tumour immunity and cancer progression.
Tuo, Baojing; Chen, Zhuang; Dang, Qin; Chen, Chen; Zhang, Hao; Hu, Shengyun; Sun, Zhenqiang.
Afiliación
  • Tuo B; Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Chen Z; Academy of Medical Sciences, Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Dang Q; Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Chen C; Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Zhang H; School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
  • Hu S; Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Sun Z; Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Cell Death Dis ; 13(6): 539, 2022 06 09.
Article en En | MEDLINE | ID: mdl-35676257
ABSTRACT
Tumour immunity plays an important role in the development of cancer. Tumour immunotherapy is an important component of antitumour therapy. Exosomes, a type of extracellular vesicle, act as mediators of intercellular communication and molecular transfer and play an essential role in tumour immunity. Circular RNAs (circRNAs) are a new type of noncoding RNA that are enriched within exosomes. In this review, we describe the effects of exosomal circRNAs on various immune cells and the mechanisms of these effects, including macrophages, neutrophils, T cells, and Natural killer (NK) cells. Next, we elaborate on the latest progress of exosome extraction. In addition, the function of exosomal circRNAs as a potential prognostic and drug sensitivity marker is described. We present the great promise of exosomal circRNAs in regulating tumour immunity, predicting patient outcomes, and evaluating drug efficacy.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exosomas / Vesículas Extracelulares / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exosomas / Vesículas Extracelulares / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: China